1) Ligustrazine phosphate
川芎嗪一号碱
2) tetramethylpyrazine
川芎嗪
1.
Study on the mensuration of tetramethylpyrazine in Zhenjiang vinegar and its generant mechanism;
镇江香醋中川芎嗪的测定及生成机理的研究
2.
Effect of tetramethylpyrazine on lipid peroxidation and antioxidant level in the brain of the developing rats following recurrent seizures;
川芎嗪对幼鼠惊厥性脑损伤脂质过氧化及抗氧化水平的影响
3.
Explore the Best Extractive Craft of Tetramethylpyrazine from Rhizoma Chuanxiong;
中药川芎中川芎嗪提取工艺优化的探索
3) ligustrazine
川芎嗪
1.
Synthesis and characterization of ligustrazine-piperazidine derivatives;
川芎嗪哌嗪衍生物的合成与表征
2.
Advance of the Studies on Structure Modifying of Ligustrazine and Bioactivities of Ligustrazine's Derivatives;
川芎嗪的结构修饰及生物活性
3.
Effect of ligustrazine on gentamicin ototoxicity-induced expression of heat shock protein 70 mRNA in stria vascularis of guinea pigs cochlea;
庆大霉素耳中毒后血管纹HSP70 mRNA的表达及川芎嗪的保护作用
4) ligustrazin
川芎嗪
1.
Effects of interaction between propofol and ligustrazin on hepatic ischemia-reperfusion injury in rat;
异丙酚和川芎嗪相互作用对大鼠肝脏缺血/再灌注损伤的影响
2.
Effects of ligustrazin on the contents of ATPase,GSH-Px,MDA in stomach,intestine and liver of severely burned rats;
川芎嗪对严重烫伤大鼠胃、肠、肝组织中ATPase,GSH-Px,MDA的影响
3.
The Protective Effect of Ligustrazin on Mitochondrion Damage in Spinal Cord Injury Rats;
川芎嗪对大鼠脊髓损伤后线粒体功能的保护作用
5) TMP
川芎嗪
1.
Clinical Study of TMP in the Treatment of 45 Cases of HIE;
川芎嗪治疗新生儿缺氧缺血性脑病临床研究
2.
Reversal of the resistance to adriamycin in human breast cancer cell line MCF-7/ADM by TMP;
川芎嗪逆转人乳腺癌MCF-7/ADM细胞对阿霉素的耐药性
3.
The effect of TMP on hyperoxia-induced lung injury;
川芎嗪对高氧肺损伤的影响
6) Ligustrazini
川芎嗪
1.
Effect of Ligustrazini on Rat Small Intestine in Acute Radiation Enteritis;
川芎嗪对大鼠急性放射性肠炎小肠的作用
2.
Effect of Ligustrazini and L-arginine on Function of Mitochondria in Myocardial Cell in the Reperfusion Injury after Myocardial Ischemia in Rabbits;
川芎嗪联合左旋精氨酸对缺血—再灌注损伤兔心肌线粒体功能的影响(英文)
3.
Effects of Ligustrazini on activation of NF-κB in pulmonary alveolar macrophages(PAM) in rabbits;
川芎嗪对肺损伤肺泡巨噬细胞中NF-κB活化的影响
补充资料:川芎嗪一号碱
分子式:暂无
分子量:暂无
CAS号:暂无
性质:暂无
制备方法:暂无
用途:抗凝血药,用于闭塞性脑血管疾病。
分子量:暂无
CAS号:暂无
性质:暂无
制备方法:暂无
用途:抗凝血药,用于闭塞性脑血管疾病。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条